Search Login Register

Erythrokeratodermia Variabilis Summary

Description: An autosomal dominant skin disease characterized by transient and variable noninflammatory ERYTHEMA and hyperkeratosis. It has been associated with mutations in the genes that code for CONNEXINS. Erythrokeratodermia variabilis inherited in an autosomal recessive fashion has also been reported. Affected individuals often develop PALMOPLANTAR KERATODERMA.

Also Known As: Erythro et Keratodermia Variabilis; Transgrediens et Progrediens Palmoplantar Keratoderma; Erythrokeratodermia Figurata Variabili; Erythrokeratodermia Variabili; Figurata Variabilis, Erythrokeratodermia Show All >>

Networked: 40 relevant articles (1 outcomes, 1 trials/studies) for this Disease

Key Drugs and Agents for Erythrokeratodermia Variabilis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Acitretin : 1 outcome in 4 results : FDA 1
  2. Etretinate : 1 study in 4 results : FDA 1
  3. human GJB3 protein : 12 results : IBA
  4. Connexins : 5 results : IBA
  5. connexin 30.3 : 4 results : IBA
  6. Retinoids : 3 results : IBA
  7. Vitamin A (Retinol) : 2 results : FDA 33 Generic
  8. loricrin : 2 results : IBA
  9. Isotretinoin (Accutane) : 1 result : FDA 6 Generic
  10. Staphylococcal Protein A (A, Protein) : 1 result : IBA
Show All >>

Diseases Related to Erythrokeratodermia Variabilis

  1. Hearing Loss (Hearing Impairment)
  2. Deafness (Deaf Mutism)
  3. Peripheral Nervous System Diseases (PNS Diseases)
  4. Netherton Syndrome
  5. Malignant Atrophic Papulosis
Show All >>

Key Therapies for Erythrokeratodermia Variabilis

Efficacy Chart >>
  1. Aftercare (After-Treatment) : 1 study in 1 result
  2. Radiotherapy : 1 result
  3. Palliative Care (Palliative Medicine) : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.